Here you find Xbrane Biopharma’s biannual shareholder letter.
If you have any questions, please don’t hesitate to contact us: firstname.lastname@example.org
Aktieägarbrev H1 2016
Shareholder letter H1 2016
Banvaktsvägen 22 17148 Solna
Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. The segment have a high entry barrier, driven by high production complexity and the need of specific Know- How.